Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209404200 on November 26, 2002

J. Biol. Chem., Vol. 278, Issue 6, 3816-3824, February 7, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/6/3816    most recent
M209404200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersson, K. B.
Right arrow Articles by Gabrielsen, O. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, K. B.
Right arrow Articles by Gabrielsen, O. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphorylation-dependent Down-regulation of c-Myb DNA Binding Is Abrogated by a Point Mutation in the v-myb Oncogene*

Kristin Brevik AnderssonDagger §, Elisabeth Kowenz-Leutz||, Elen Margrethe BrendefordDagger , Ann-Helen Herwig TygsettDagger , Achim Leutz||, and Odd S. GabrielsenDagger **

From the Dagger  Department of Biochemistry, University of Oslo, N-0316 Oslo, Norway and the || Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13092 Berlin, Germany

The viral Myb (v-Myb) oncoprotein of the avian myeloblastosis virus (AMV) is an activated form of the cellular transcription factor c-Myb causing acute monoblastic leukemia in chicken. Oncogenic v-Myb alterations include N- and C-terminal deletions as well as point mutations. Whereas truncations in Myb cause loss of various protein modifications, none of the point mutations in v-Myb has been directly linked to protein modifications. Here we show that the DNA-binding domain of c-Myb can be phosphorylated on serine 116 by the catalytic subunit of protein kinase A. Phosphorylation of Ser116 differentially destabilizes a subtype of c-Myb-DNA complexes. The V117D mutation of the AMV v-Myb oncoprotein abolishes phosphorylation of the adjacent Ser116 residue. Modification of Ser116 was also detected in live cells in c-Myb, but not in AMV v-Myb. Phosphorylation-mimicking mutants of c-Myb failed to activate the resident mim-1 gene. Our data imply that protein kinase A or a kinase with similar specificity negatively regulates c-Myb function, including collaboration with C/EBP, and that the leukemogenic AMV v-Myb version evades inactivation by a point mutation that abolishes a phosphoacceptor consensus site. This suggests a novel link between Myb, a signal transduction pathway, cooperativity with C/EBP, and a point mutation in the myb oncogene.


* This work was supported by the Norwegian Cancer Society (to K. B. A., E. M. B., and O. S. G.), the Norwegian Research Council (to O. S. G.), the Anders Jahre Foundation (to O. S. G.), the Blix Foundation for Medical Research (to K. B. A.), and the Deutsche Forschungsgemeinschaft (to E. K. L. and A. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Institute for Experimental Medical Research, Ullevål Hospital, 0407 Oslo, Norway.

The two first authors contributed equally to the work.

** To whom correspondence should be addressed: Dept. of Biochemistry, University of Oslo, P.O. Box 1041 Blindern, 0316 Oslo, Norway. Tel.: 47-22-85-73-46; Fax: 47-22-85-44-43; E-mail: O.S.Gabrielsen@ biokjemi.uio.no.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Fang, M. A. Rycyzyn, and C. V. Clevenger
Role of c-Myb during Prolactin-Induced Signal Transducer and Activator of Transcription 5a Signaling in Breast Cancer Cells
Endocrinology, April 1, 2009; 150(4): 1597 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. K. Purbey, S. Singh, D. Notani, P. P. Kumar, A. S. Limaye, and S. Galande
Acetylation-Dependent Interaction of SATB1 and CtBP1 Mediates Transcriptional Repression by SATB1
Mol. Cell. Biol., March 1, 2009; 29(5): 1321 - 1337.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Saether, T. Berge, M. Ledsaak, V. Matre, A. H. Alm-Kristiansen, O. Dahle, F. Aubry, and O. S. Gabrielsen
The Chromatin Remodeling Factor Mi-2{alpha} Acts as a Novel Co-activator for Human c-Myb
J. Biol. Chem., May 11, 2007; 282(19): 13994 - 14005.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Fukuzawa, N. V. Zhukovskaya, Y. Yamada, T. Araki, and J. G. Williams
Regulation of Dictyostelium prestalk-specific gene expression by a SHAQKY family MYB transcription factor
Development, May 1, 2006; 133(9): 1715 - 1724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement